GB201812079D0 - Selection method - Google Patents

Selection method

Info

Publication number
GB201812079D0
GB201812079D0 GBGB1812079.0A GB201812079A GB201812079D0 GB 201812079 D0 GB201812079 D0 GB 201812079D0 GB 201812079 A GB201812079 A GB 201812079A GB 201812079 D0 GB201812079 D0 GB 201812079D0
Authority
GB
United Kingdom
Prior art keywords
selection method
selection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1812079.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogaia AB
Original Assignee
Biogaia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia AB filed Critical Biogaia AB
Priority to GBGB1812079.0A priority Critical patent/GB201812079D0/en
Publication of GB201812079D0 publication Critical patent/GB201812079D0/en
Priority to SG11202010900PA priority patent/SG11202010900PA/en
Priority to PCT/EP2019/069984 priority patent/WO2020020982A1/en
Priority to JP2021503787A priority patent/JP2021531015A/en
Priority to EP19742228.0A priority patent/EP3827102A1/en
Priority to CN201980044643.7A priority patent/CN112739814B/en
Priority to HUE19742381A priority patent/HUE059963T2/en
Priority to BR112020023868-6A priority patent/BR112020023868A2/en
Priority to US17/251,410 priority patent/US20230057324A1/en
Priority to RS20220933A priority patent/RS63624B1/en
Priority to DK19742381.7T priority patent/DK3701051T3/en
Priority to EP19742381.7A priority patent/EP3701051B1/en
Priority to MA50489A priority patent/MA50489B1/en
Priority to LTEPPCT/EP2019/069984T priority patent/LT3701051T/en
Priority to KR1020207033397A priority patent/KR20210035077A/en
Priority to PL19742381.7T priority patent/PL3701051T3/en
Priority to CA3099255A priority patent/CA3099255A1/en
Priority to EP22165915.4A priority patent/EP4086359A1/en
Priority to JP2020570056A priority patent/JP7488199B2/en
Priority to MX2020012770A priority patent/MX2020012770A/en
Priority to PCT/EP2019/069987 priority patent/WO2020020984A1/en
Priority to GEAP201915500A priority patent/GEP20237507B/en
Priority to PT197423817T priority patent/PT3701051T/en
Priority to CA3103356A priority patent/CA3103356A1/en
Priority to ES19742381T priority patent/ES2928223T3/en
Priority to HRP20221209TT priority patent/HRP20221209T1/en
Priority to AU2019309426A priority patent/AU2019309426A1/en
Priority to CN201980036257.3A priority patent/CN112236513B/en
Priority to MX2020014222A priority patent/MX2020014222A/en
Priority to TW108126201A priority patent/TW202019448A/en
Priority to CN202311089611.3A priority patent/CN117487686A/en
Priority to US16/961,598 priority patent/US11911424B2/en
Priority to IL305597A priority patent/IL305597B1/en
Priority to ZA2020/06891A priority patent/ZA202006891B/en
Priority to PH12020551922A priority patent/PH12020551922A1/en
Priority to CL2020003070A priority patent/CL2020003070A1/en
Priority to CONC2020/0014673A priority patent/CO2020014673A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03031—Nucleotidase (3.1.3.31)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB1812079.0A 2018-07-24 2018-07-24 Selection method Ceased GB201812079D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GBGB1812079.0A GB201812079D0 (en) 2018-07-24 2018-07-24 Selection method
PCT/EP2019/069984 WO2020020982A1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
JP2020570056A JP7488199B2 (en) 2018-07-24 2019-07-24 Selection and use of melatonin-assisted bacteria to alleviate infant colic
PCT/EP2019/069987 WO2020020984A1 (en) 2018-07-24 2019-07-24 Therapeutic methods using bacterial strains which are capable of increasing adenosine levels
JP2021503787A JP2021531015A (en) 2018-07-24 2019-07-24 Treatment with bacterial strains that can increase adenosine levels
MX2020012770A MX2020012770A (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic.
CN201980044643.7A CN112739814B (en) 2018-07-24 2019-07-24 Methods of treatment using bacterial strains capable of increasing adenosine levels
HUE19742381A HUE059963T2 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
BR112020023868-6A BR112020023868A2 (en) 2018-07-24 2019-07-24 LACTIC ACID BACTERIAL CEPA, METHODS FOR THE SELECTION OF A LACTIC ACID BACTERIAL CEPA AND TO PRODUCE MELATONIN IN AN INDIVIDUAL, COMBINATION PRODUCT, AND, USE OF A LACTIC ACID BACTERIAL CEPA.
US17/251,410 US20230057324A1 (en) 2018-07-24 2019-07-24 Therapeutic Methods Using Bacterial Strains Which are Capable of Increasing Adenosine Levels
RS20220933A RS63624B1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
DK19742381.7T DK3701051T3 (en) 2018-07-24 2019-07-24 SELECTION AND USE OF MELATONIN SUPPORTING BACTERIA FOR THE REDUCTION OF INFANT COLIC
EP19742381.7A EP3701051B1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
MA50489A MA50489B1 (en) 2018-07-24 2019-07-24 Selection and use of bacteria promoting melatonin production to reduce infantile colic
LTEPPCT/EP2019/069984T LT3701051T (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
KR1020207033397A KR20210035077A (en) 2018-07-24 2019-07-24 Selection and use of melatonin-supporting bacteria to reduce colic in infants and toddlers
PL19742381.7T PL3701051T3 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
CA3099255A CA3099255A1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
EP22165915.4A EP4086359A1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
SG11202010900PA SG11202010900PA (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
EP19742228.0A EP3827102A1 (en) 2018-07-24 2019-07-24 Therapeutic methods using bacterial strains which are capable of increasing adenosine levels
IL305597A IL305597B1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
PT197423817T PT3701051T (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
GEAP201915500A GEP20237507B (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
CA3103356A CA3103356A1 (en) 2018-07-24 2019-07-24 Therapeutic methods using bacterial strains which are capable of increasing adenosine levels
ES19742381T ES2928223T3 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infant colic
HRP20221209TT HRP20221209T1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
AU2019309426A AU2019309426A1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
CN201980036257.3A CN112236513B (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce colic in infants
MX2020014222A MX2020014222A (en) 2018-07-24 2019-07-24 Therapeutic methods using bacterial strains which are capable of increasing adenosine levels.
TW108126201A TW202019448A (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
CN202311089611.3A CN117487686A (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce colic in infants
US16/961,598 US11911424B2 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic
ZA2020/06891A ZA202006891B (en) 2018-07-24 2020-11-04 Selection and use of melatonin supporting bacteria to reduce infantile colic
PH12020551922A PH12020551922A1 (en) 2018-07-24 2020-11-11 Selection and use of melatonin supporting bacteria to reduce infantile colic
CL2020003070A CL2020003070A1 (en) 2018-07-24 2020-11-26 Selection and Use of Melatonin Support Bacteria to Reduce Infant Colic
CONC2020/0014673A CO2020014673A2 (en) 2018-07-24 2020-11-26 Selection and use of bacteria that support melatonin to reduce infant colic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1812079.0A GB201812079D0 (en) 2018-07-24 2018-07-24 Selection method

Publications (1)

Publication Number Publication Date
GB201812079D0 true GB201812079D0 (en) 2018-09-05

Family

ID=63364334

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1812079.0A Ceased GB201812079D0 (en) 2018-07-24 2018-07-24 Selection method

Country Status (3)

Country Link
GB (1) GB201812079D0 (en)
MA (1) MA50489B1 (en)
TW (1) TW202019448A (en)

Also Published As

Publication number Publication date
TW202019448A (en) 2020-06-01
MA50489A (en) 2020-09-02
MA50489B1 (en) 2022-10-31

Similar Documents

Publication Publication Date Title
GB201808474D0 (en) Method
GB201800298D0 (en) Method
GB201807793D0 (en) Method
GB201808554D0 (en) Method
GB201809323D0 (en) Method
GB201811813D0 (en) Method
GB201811811D0 (en) Method
GB201805876D0 (en) Method
GB201811810D0 (en) Method
GB201800558D0 (en) Method
GB201808663D0 (en) Method
GB201804277D0 (en) Method
GB201812603D0 (en) Method
GB201809403D0 (en) Method
GB201806240D0 (en) Method
GB201803750D0 (en) Method
GB201808558D0 (en) Method
GB201807788D0 (en) Method
GB201807041D0 (en) Method
GB201803183D0 (en) Method
GB201802653D0 (en) Method
GB201801169D0 (en) Method
GB201800187D0 (en) Method
GB201812079D0 (en) Selection method
GB201812746D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)